Enteris expands manufacturing, launches CDMO business unit

By The Science Advisory Board staff writers

May 3, 2021 -- Enteris BioPharma has expanded its Boonton, NJ, manufacturing facility and launched a contract development and manufacturing organization (CDMO) business unit.

The two actions will help the firm further develop and manufacture solid oral doses for biopharmaceutics classification system (BCS) III and IV compounds, it said.

The expanded facility is 32,000 sq ft, of which 6,000 sq ft is cleanroom space and 2,500 is for containment and processing of high-potency active pharmaceutical ingredients (APIs).

Copyright © 2021 scienceboard.net

To read this and get access to all of the exclusive content on The Science Advisory Board create a free account or sign-in now.

Member Sign In:
MemberID or email address:  
Do you have a Scienceboard.net password?
No, I want a free membership.
Yes, I have a password:  
Forgot your password?